Steven D. Criss

509 total citations
15 papers, 380 citations indexed

About

Steven D. Criss is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Economics and Econometrics. According to data from OpenAlex, Steven D. Criss has authored 15 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 4 papers in Economics and Econometrics. Recurrent topics in Steven D. Criss's work include Global Cancer Incidence and Screening (5 papers), Lung Cancer Diagnosis and Treatment (5 papers) and Economic and Financial Impacts of Cancer (4 papers). Steven D. Criss is often cited by papers focused on Global Cancer Incidence and Screening (5 papers), Lung Cancer Diagnosis and Treatment (5 papers) and Economic and Financial Impacts of Cancer (4 papers). Steven D. Criss collaborates with scholars based in United States, Netherlands and Vietnam. Steven D. Criss's co-authors include Chung Yin Kong, Deirdre F. Sheehan, Yufan Chen, Meghan J. Mooradian, Tina R. Watson, Justin F. Gainor, Kerry L. Reynolds, Angela C. Tramontano, Mehrad Bastani and Chin Hur and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Internal Medicine and PLoS ONE.

In The Last Decade

Steven D. Criss

14 papers receiving 374 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steven D. Criss United States 10 234 234 75 68 45 15 380
Daniel J. Boffa United States 12 374 1.6× 223 1.0× 89 1.2× 48 0.7× 79 1.8× 24 532
S. Memon Canada 10 150 0.6× 156 0.7× 58 0.8× 35 0.5× 57 1.3× 24 304
Scott M. Atay United States 11 225 1.0× 121 0.5× 90 1.2× 21 0.3× 36 0.8× 49 433
Katherine Tullio United States 6 92 0.4× 217 0.9× 52 0.7× 74 1.1× 28 0.6× 24 315
Eija‐Riitta Salomaa Finland 10 474 2.0× 162 0.7× 152 2.0× 16 0.2× 38 0.8× 18 628
Liang G. Qu Australia 9 61 0.3× 123 0.5× 53 0.7× 45 0.7× 24 0.5× 32 326
Kim Moretti Australia 13 292 1.2× 142 0.6× 103 1.4× 32 0.5× 34 0.8× 48 440
Tyler J. Nelson United States 8 129 0.6× 91 0.4× 35 0.5× 35 0.5× 26 0.6× 38 263
Timur Mitin United States 9 97 0.4× 162 0.7× 58 0.8× 23 0.3× 97 2.2× 30 290
Daniel Cherry United States 9 112 0.5× 122 0.5× 44 0.6× 38 0.6× 20 0.4× 28 271

Countries citing papers authored by Steven D. Criss

Since Specialization
Citations

This map shows the geographic impact of Steven D. Criss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven D. Criss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven D. Criss more than expected).

Fields of papers citing papers by Steven D. Criss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven D. Criss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven D. Criss. The network helps show where Steven D. Criss may publish in the future.

Co-authorship network of co-authors of Steven D. Criss

This figure shows the co-authorship network connecting the top 25 collaborators of Steven D. Criss. A scholar is included among the top collaborators of Steven D. Criss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven D. Criss. Steven D. Criss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
2.
Criss, Steven D., et al.. (2023). The Healthcare Experience of Autistic Patients in Orthopaedic Surgery and Closely Related Fields: A Scoping Review. Children. 10(5). 906–906. 2 indexed citations
3.
Coe, Taylor M., Steven D. Criss, Stephen J. Bartels, et al.. (2023). Preferred language and disease severity predict evaluation for liver transplantation among patients admitted with alcohol-associated hepatitis. European Journal of Gastroenterology & Hepatology. 35(8). 907–913. 1 indexed citations
4.
Criss, Steven D., et al.. (2022). Acceptability and utility of a virtual pediatric transplant peer mentoring program: A mixed‐methods analysis of a novel quality improvement program. Pediatric Transplantation. 26(7). e14345–e14345. 3 indexed citations
5.
Criss, Steven D., et al.. (2020). Cost-effectiveness of pembrolizumab for advanced non-small cell lung cancer patients with varying comorbidity burden. PLoS ONE. 15(1). e0228288–e0228288. 12 indexed citations
6.
Chen, Yufan, et al.. (2019). A simulation study of the effect of lung cancer screening in China, Japan, Singapore, and South Korea. PLoS ONE. 14(7). e0220610–e0220610. 7 indexed citations
7.
Chen, Yufan, Steven D. Criss, Tina R. Watson, et al.. (2019). Cost and Utilization of Lung Cancer End-of-Life Care Among Racial-Ethnic Minority Groups in the United States. The Oncologist. 25(1). e120–e129. 23 indexed citations
8.
Criss, Steven D., Meghan J. Mooradian, Tina R. Watson, et al.. (2019). Cost-effectiveness of Atezolizumab Combination Therapy for First-Line Treatment of Metastatic Nonsquamous Non–Small Cell Lung Cancer in the United States. JAMA Network Open. 2(9). e1911952–e1911952. 56 indexed citations
9.
Criss, Steven D., Pianpian Cao, Mehrad Bastani, et al.. (2019). Cost-Effectiveness Analysis of Lung Cancer Screening in the United States. Annals of Internal Medicine. 171(11). 796–804. 89 indexed citations
10.
Kong, Chung Yin, Keith Sigel, Steven D. Criss, et al.. (2018). Benefits and harms of lung cancer screening in HIV-infected individuals with CD4+ cell count at least 500 cells/μl. AIDS. 32(10). 1333–1342. 31 indexed citations
11.
Criss, Steven D., et al.. (2018). Population impact of lung cancer screening in the United States: Projections from a microsimulation model. PLoS Medicine. 15(2). e1002506–e1002506. 20 indexed citations
12.
Criss, Steven D., Davis T. Weaver, Deirdre F. Sheehan, et al.. (2018). Effect of PD-L1 testing on the cost-effectiveness and budget impact of pembrolizumab for advanced urothelial carcinoma of the bladder in the United States. Urologic Oncology Seminars and Original Investigations. 37(3). 180.e11–180.e18. 15 indexed citations
14.
Sheehan, Deirdre F., Steven D. Criss, Yufan Chen, et al.. (2018). Lung cancer costs by treatment strategy and phase of care among patients enrolled in Medicare. Cancer Medicine. 8(1). 94–103. 64 indexed citations
15.
Sheehan, Deirdre F., Steven D. Criss, G. Scott Gazelle, Pari V. Pandharipande, & Chung Yin Kong. (2017). Evaluating lung cancer screening in China: Implications for eligibility criteria design from a microsimulation modeling approach. PLoS ONE. 12(3). e0173119–e0173119. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026